KP Tissue Inc. (KPT.TO)
CAD 8.17
(0.37%)
CAD 8.17
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 830 Thousand | -12.54 Million | -321 Thousand | -634 Thousand | 574 Thousand | 196 Thousand |
| Selling, General and Administrative Expenses | 830 Thousand | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -12.54 Million | -321 Thousand | -634 Thousand | 574 Thousand | 196 Thousand |
| Cost and Expenses | 830 Thousand | -12.54 Million | -321 Thousand | -634 Thousand | 574 Thousand | 196 Thousand |
| Operating Income | - | -12.54 Million | -321 Thousand | -634 Thousand | -574 Thousand | 1.58 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 4.1 Million | -2.29 Million | -118 Thousand | 1.15 Million | 1.72 Million | 1.75 Million |
| Earnings before Tax | -830 Thousand | -12.54 Million | 1.12 Million | -794 Thousand | -4.8 Million | 1.58 Million |
| Net Income | -4.93 Million | -10.24 Million | 1.23 Million | -1.95 Million | -6.52 Million | -173 Thousand |
| Earnings Per Share Basic | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 |
| Earnings Per Share Diluted | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 |
| Weighted Average Shares Outstanding | 9.95 Million | 9.93 Million | 9.83 Million | 9.7 Million | 9.54 Million | 9.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.95 Million | 9.93 Million | 9.83 Million | 9.7 Million | 9.54 Million | 9.31 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 238.6 Million | 752 Thousand | 153.43 Million | 197.83 Million | 145.03 Million | -196 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | -131 Thousand | -262 Thousand | 830 Thousand | 1.93 Million | -262 Thousand | -252 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -131 Thousand | -262 Thousand | -1.86 Million | 1.93 Million | -262 Thousand | -252 Thousand |
| Cost and Expenses | -131 Thousand | -262 Thousand | 830 Thousand | 1.93 Million | -262 Thousand | -252 Thousand |
| Operating Income | -131 Thousand | -262 Thousand | -1.86 Million | 1.93 Million | -262 Thousand | -252 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -65.27 Million | -67.08 Million | 4.1 Million | 215 Thousand | -72.38 Thousand | -55.04 Thousand |
| Earnings before Tax | 1.19 Million | 1.13 Million | 1.03 Million | 245 Thousand | 1.76 Million | 2.01 Million |
| Net Income | 1.19 Million | 1.13 Million | -4.93 Million | 1.96 Million | 1.76 Million | 2.01 Million |
| Earnings Per Share Basic | 0.12 | 0.11 | - | 0.20 | 0.18 | 0.20 |
| Earnings Per Share Diluted | 0.12 | 0.11 | - | 0.20 | 0.18 | 0.20 |
| Weighted Average Shares Outstanding | 9.97 Million | 9.96 Million | 9.95 Million | 9.96 Million | 9.95 Million | 9.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.97 Million | 9.96 Million | 9.95 Million | 9.96 Million | 9.95 Million | 9.95 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -131 Thousand | -262 Thousand | - | -245 Thousand | -262 Thousand | -252 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
OPOF
UVDRHOR
RWAY
IAM
HBRIY
KMEZ